(marketscreener.com) Shanghai, China, 30 July 2021 - MicroPort® CardioFlow Medtech Corporation has recently entered into a simple agreement for future equity with Valcare, Inc. , a start-up focusing on innovative transcatheter technology, following the recent conclusion of CardioFlow Medtech's first investment via SAFE. Through this new agreement,...https://www.marketscreener.com/quote/stock/MICROPORT-SCIENTIFIC-CORP-6727702/news/MicroPort-Scientific-CardioFlow-Medtech-Makes-Follow-on-Investment-in-Transcatheter-Valve-Start-up-36015809/?utm_medium=RSS&utm_content=20210730
Valcare is an Israel-based medical device company that designs and develops transcatheter technology solutions for the treatment of mitral and tricuspid regurgitation.